Tailocins: The headless phage in fight against bacteria

INTERVIEW

What’s Better: Simplicity or Standardization in Bacteriophage Nomenclature?

Starter package

Understanding Enveloped and Non-Enveloped Viruses

NEWS

Discovery: Bacteriophages Turn Bacteria into ‘Zombie’ Cells

Phage and AI come together to fight antimicrobial resistance at Phagos

July 8, 2025

Recently, Amazon has published an article on Phagos. Phagos an AI tech-bio start-up company, has utilized Amazon Web Services(AWS) to develop an AI model….

Intralytix using Phages as Precision Medicine

July 2, 2025

Moving away from the traditional “one-size-fits-all” approach to medicine, the precision medicine approach tailors treatment and prevention strategies to an individual’s unique characteristics, aiming…

Enveloped vs Non-Enveloped Viruses: Key Differences, Structure & Examples

June 29, 2025

Understanding the difference between enveloped and non-enveloped viruses is key to virology, infection control, and antiviral development. This guide dives deep into their structure,…

CRISPR armed phage therapeautic to treat cancer patients

June 26, 2025

SNIPR Biome has conducted a randomized, double-blinded, placebo-controlled clinical trial. This is a Phase 1b clinical trial of SNIPR001 in patients with hematological cancer….

Shrimp Hatchery Rearing Systems to Utilize phages in fight against aquatic bacterial infections

June 17, 2025

Indian Council of Agricultural Research(ICAR) and Central Institute of Brackishwater Aquaculture(CIBA) signed a memorandum of Understanding(MoU) with M/s Salem Microbes Private Limited, Salem, Tamil Nadu,…

Conference on phages: Biology, Dynamics, and Therapeutics

June 9, 2025

The International Antiviral Society -USA has announced a 2.5-day conference on phages. Approximately 500 US and international attendees will be attending this conference. Being…

UK Issues Pivotal Guidelines to Advance Safe Development of Phage Therapies

June 7, 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has released a comprehensive new document aimed at guiding researchers and pharmaceutical companies in the safe…

ARMATA Pharmaceuticals, phage trial data

Positive data from IV administered AP-SA02 in Staphylococcus aureus Bacteremia(SAB)-Armata pharmaceuticals

June 5, 2025

Staphylococcus aureus bacteremia (SAB) is a bloodstream infection caused by Staphylococcus aureus, associated with significant morbidity and mortality. Staphylococcus aureus bacteremia (SAB) continues to be a…

Nebulized phage therapy treats cystic fibrosis cases

May 13, 2025

The incidence of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) is alarming. And so are the MDR(Multi-drug resistant) cases and PDR(PAN drug-resistant) cases…

Phage therapy as “One-Health” approach in aquaculture

May 6, 2025

The overuse of antibiotics has led to antimicrobial resistance, now with scientific society looking out for potential alternatives not only for human usage but…

The Phage